Skip to main content
$118.19 $0.65 (0.6%)

04:00 PM EDT on 07/23/21

AbbVie Inc. (NYSE:ABBV)

CAPS Rating: 5 out of 5

Current Price $118.19 Mkt Cap $208.7B
Open $117.98 P/E Ratio 40.39
Prev. Close $118.19 Div. (Yield) $5.20 (4.4%)
Daily Range $117.57 - $118.67 Volume 4,411,471
52-Wk Range $79.11 - $118.67 Avg. Daily Vol. 6,294,199

Caps

How do you think NYSE:ABBV will perform against the market?

Add Stock to CAPS Watchlist

All Players

621 Outperform
10 Underperform
 

All-Star Players

132 Outperform
1 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NYSE:ABBV Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

bdbcalm (< 20)
Submitted February 15, 2015

Sold off due to patent cliff concerns and Hep C drug discounts. I believe this is an overreaction and the stock will recover. There is more in the pipeline than the P/E - 13 - would imply.

TMFSpiffyPop (99.86)
Submitted January 09, 2015

This mega-cap has made a big run since Express Scripts's announcement that it will take AbbVie's hep C treatment in lieu of Gilead's. Also, an amazing preponderance of CAPS bulls favor this stock beating the market from here -- very interesting. For… More

Recent Community Commentary

Read the most recent pitches from players about ABBV.

Recs

0
Member Avatar Millions2021 (< 20) Submitted: 7/11/2021 6:45:46 PM : Outperform Start Price: $115.52 NYSE:ABBV Score: +1.28

Great growth.

Recs

0
Member Avatar cwardfs (< 20) Submitted: 3/5/2021 7:50:01 PM : Outperform Start Price: $103.52 NYSE:ABBV Score: -0.11

This is my biopharmaceutical choice.

Recs

0
Member Avatar BretterThanMost (40.95) Submitted: 2/6/2021 5:27:26 PM : Outperform Start Price: $78.07 NYSE:ABBV Score: -1.35

The decision to acquire Allergan to diversify the company's revenue stream away from Humira appears to have been an excellent one and the ongoing absorption of Allergan appears to be going smoothly. Decent growth prospects for sales per share and the current dividend, now at 4.78%, are likely to produce above average total returns over the next decade.

Leaderboard

Find the members with the highest scoring picks in ABBV.

Score Leader

GW1000

GW1000 (88.71) Score: +202.25

The Score Leader is the player with the highest score across all their picks in ABBV.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
armydave 74.16 1/10/2013 12/6/2017 Outperform 5Y $23.54 +402.08% +199.83% +202.25 0 Comment
pirotta < 20 1/10/2013 Outperform 5Y $23.54 +402.08% +199.83% +202.25 0 Comment
deliman723 64.17 1/10/2013 Outperform 5Y $23.54 +402.08% +199.83% +202.25 0 Comment
concealedweaponR < 20 1/10/2013 Outperform 5Y $23.54 +402.08% +199.83% +202.25 0 Comment
drjohn432 < 20 1/10/2013 10/25/2020 Outperform 5Y $23.54 +402.08% +199.83% +202.25 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. valari25 97.72 1/10/2013 9/2/2020 Outperform 5Y $23.54 +402.08% +199.83% +202.25 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. GW1000 88.71 1/10/2013 7/6/2018 Outperform 5Y $23.54 +402.08% +199.83% +202.25 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. mattmmurphy 70.35 1/10/2013 Outperform 5Y $23.54 +402.08% +199.83% +202.25 0 Comment
cooleyly 48.44 1/10/2013 Outperform 5Y $23.54 +402.08% +199.83% +202.25 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. kinosternon 97.35 1/9/2013 Outperform 5Y $23.65 +399.80% +201.22% +198.59 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for ABBV.